Back to search

Article

Spliceosome Inhibition in <i>SF3B1</i>-Mutated Uveal Melanoma

2022-09-23

Abstract excerpt

Treatment of uveal melanoma (UM) patients with metastatic disease is unfortunately limited. Twenty percent of UM harbor a mutation in splicing factor gene SF3B1 , suggesting that aberrant spliceosome functioning plays a vital role in tumorigenesis. Splicing inhibitors exploit the preferential sensitivity of spliceosome compromised leukemic cells to these compounds. We have studied the effect of splicing inhibitor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8436ac1a-7ec2-5424-8a69-0d597071701c
DOI
10.1101/2022.09.20.22280164
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Spliceosome Inhibition in <i>SF3B1</i>-Mutated Uveal MelanomaDOI 10.1101/2022.09.20.22280164
Select a neighboring publication to make it the new centre.